• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Carrie Stricker on Why Clinician Voices Are Needed in Health IT Development

Video

The most transformative software companies are those that have seized the opportunity to incorporate clinician and patient voices into the design of their health IT tools, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

The most transformative software companies are those that have seized the opportunity to incorporate clinician and patient voices into the design of their health information technology (IT) tools, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.

Transcript (slightly modified)

What are some oncology challenges that can be turned into opportunities with health IT?

Well, it’s interesting, coming off this panel one of the big things that we talked about is workflow. That so much of what health IT is available to clinicians and care teams right now has not been designed with attention to workflow at the point of care. And all the panel members today in the “Surmounting IT Challenges” section of the conference today highlighted, myself included, what an opportunity that is.

Suzanne [Belinson] with BlueCross, I think stated it very well [at the Patient-Centered Oncology Care meeting]. She said now it is the companies who have either clinicians at their leadership level and/or who are dedicated to bringing clinicians and care teams in the process of designing software that are really being disruptive in the most positive sense of that term, transforming how health IT supports providers, care teams, and patients and families by bringing their voices into the development and ensuring that they’re a part of the solution of designing and testing and improving these health IT solutions. That’s the crux of it.

Related Videos
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Dr Marco del Riccio
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Michael David Chuong, MD, radiation oncologist, Miami Cancer Institute, Baptist Health South Florida
Yuman Fong, MD, cancer surgeon, City of Hope
Dr Marco del Riccio
Elena Elimova, MD, associate professor in the Department of Medicine at the University of Toronto and staff medical oncologist at Princess Margaret Hospital
Dr Eric Yang
Adam Brufsky, MD, PhD, University of Pittsburgh
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
© 2026 MJH Life Sciences
AJMC®
All rights reserved.